Annie Penn Cancer Center
Reidsville, North Carolina, United States
Cancer treatment center in Reidsville, North Carolina
inside Annie Penn Hospital, 618 S Main St, Reidsville, NC 27320
About Annie Penn Cancer Center
"Located in Annie Penn Hospital, the Cone Health Cancer Center at Annie Penn offers comprehensive, leading-edge services in the area of cancer care. We specialize in the treatment of multiple cancer types including breast cancer, prostate cancer, colon cancer, skin cancer and more."
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Annie Penn Cancer Center
During the past decade, Annie Penn Cancer Center conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 19 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 4 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study of the Efficacy and Safety of Ocrelizumab in Patients With Relapsing-Remitting Multiple Sclerosis
2008-07-17
2023-12-16
Active, not recruiting
220
A Study of Ocrelizumab in Participants With Primary Progressive Multiple Sclerosis
2011-03-02
2022-12-31
Completed
735
A Study of Atezolizumab in Combination With Carboplatin or Cisplatin + Pemetrexed Compared With Carboplatin or Cisplatin + Pemetrexed in Participants Who Are Chemotherapy-Naive and Have Stage IV Non-Squamous Non-Small Cell Lung Cancer (NSCLC) (IMpower 132)
2016-04-30
2022-12-13
Completed
578
A Study Evaluating the Efficacy and Safety of Crenezumab Versus Placebo in Participants With Prodromal to Mild Alzheimer's Disease (AD).
2016-03-22
2019-05-31
Terminated
813
A Study of Tiragolumab in Combination With Atezolizumab in Chemotherapy-Naïve Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
2018-08-10
2024-03-31
Active, not recruiting
135
Non-interventional Study of Ocrelizumab in Participants With Relapsing or Primary Progressive Multiple Sclerosis
2018-11-12
2025-07-26
Active, not recruiting
1,700
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of a Higher Dose of Ocrelizumab in Adults With Relapsing Multiple Sclerosis (RMS)
2020-11-26
2029-03-30
Recruiting
865
A Study to Evaluate the Efficacy and Safety of Fenebrutinib Compared With Ocrelizumab in Adult Participants With Primary Progressive Multiple Sclerosis
2020-10-26
2026-12-18
Recruiting
946
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Annie Penn Cancer Center" #1 sponsor was "Alliance for Clinical Trials in Oncology" with 12 trials, followed by "SWOG Cancer Research Network" with 8 trials
sponsored, "ECOG-ACRIN Cancer Research Group" with 4 trials sponsored, "NSABP Foundation Inc" with 4 trials sponsored and "Radiation Therapy Oncology Group"
with 4 trials sponsored. Other sponsors include -3 different institutions and
companies that sponsored additional 7 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Annie Penn Cancer Center"
#1 collaborator was "National Cancer Institute (NCI)" with 34 trials as a collaborator, "Cancer and Leukemia Group B" with 5 trials as a collaborator, "NCIC Clinical Trials Group" with 5 trials as a collaborator, "SWOG Cancer Research Network" with 5 trials as a collaborator and "NRG Oncology" with 2 trials as a collaborator. Other collaborators include 3 different institutions and companies that were
collaborators in the rest 12 trials.
Clinical Trials Conditions at Annie Penn Cancer Center
According to Clinical.Site data, the most researched conditions in "Annie Penn Cancer Center" are
"Breast Cancer" (7 trials), "Lung Cancer" (5 trials), "Colorectal Cancer" (3 trials), "Prostate Cancer" (3 trials) and "Esophageal Cancer" (2 trials). Many other conditions were trialed in "Annie Penn Cancer Center" in a lesser frequency.
Clinical Trials Intervention Types at Annie Penn Cancer Center
Most popular intervention types in "Annie Penn Cancer Center" are "Drug" (26 trials), "Biological" (13 trials), "Other" (11 trials), "Radiation" (5 trials) and "Procedure" (3 trials). Other intervention types were less common.
The name of intervention was led by "bevacizumab" (6 trials), "placebo" (5 trials), "cetuximab" (3 trials), "cisplatin" (3 trials) and "cyclophosphamide" (3 trials). Other intervention names were less common.
Clinical Trials Genders at Annie Penn Cancer Center
The vast majority of trials in "Annie Penn Cancer Center" are
23 trials for "All" genders, 8 trials for "Female" genders and 3 trials for "Male" genders.
Clinical Trials Status at Annie Penn Cancer Center
Currently, there are NaN active trials in "Annie Penn Cancer Center".
undefined are not yet recruiting,
undefined are recruiting,
4 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 26 completed trials in Annie Penn Cancer Center,
undefined suspended trials,
and 3 terminated clinical trials to date.
Out of the total trials that were conducted in Annie Penn Cancer Center, 1 "Phase 1"
clinical trials were conducted, 10 "Phase 2" clinical
trials and 21 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".